Description: Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The company's test is based on database containing prostate cancer patients, as well as provides decision support for patients and doctors when making a treatment decision. Prostatype Genomics AB (publ) was incorporated in 2007 and is based in Solna, Sweden.
Home Page: www.prostatypegenomics.com
Gustaf III:s Boulevard 34
Solna,
169 73
Sweden
Phone:
46 08 20 87 00
Officers
| Name | Title |
|---|---|
| Mr. Fredrik Rickman | CEO & MD |
| Mr. Anders Koch | Chief Financial Officer |
| George Skinner | Vice President Commercial operations |
| Ms. Emelie Berglund | Chief Technology Officer |
| Mr. Nicklas Rosendal | Communications Director |
| Joakim Soderin | Chief Auditor |
| Prof. Gerald L. Andriole Jr., M.D. | Global Chief Medical Officer |
| Mr. Steven Gaal | President US operations |
| Katarina Sjöberg | QA & RA Manager |
| Mats Bergström | Sales Director of EMEA |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.4093 |
| Price-to-Sales TTM: | 0.0015 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 6 |